Trinity Biosystems

About:

Trinity Biosystems develops oral therapeutic proteins and vaccines for respiratory, digestive and sexually transmitted diseases.

Website: http://www.trinitybiosystems.com

Top Investors: EQT Life Sciences, SR One, Amgen Ventures, GSK, Sanderling Ventures

Description:

Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases, as well as transporting proteins, peptides, and other macromolecules. The company was founded in 2002 and is based in Menlo Park, California.

Total Funding Amount:

$30M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2002-01-01

Contact Email:

busdev(AT)trinitybiosystems.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-11-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai